🏢 官网IRJAZZCodex · 实盘不做把握 9/10
北京时间·🕒 发布 04:15:00时区推断·⟳ 抓取 04:17:46回填·⚡ 决策 07-21 04:18:51·98.8 天前
Jazz Pharmaceuticals宣布将于2026年8月3日盘后披露二季度财报
该公告仅是财报披露日期和电话会安排，不包含业绩数据、指引变化、产品进展、监管结果或交易对手信息。
📄 原文JAZZ↗ 原文
Jazz Pharmaceuticals to Report Second Quarter Financial Results on August 3, 2026
Skip to main navigation Top Bar Nav Contact Us Social Icons linkedin twitter Home Jazz Pharmaceuticals to Report Second…
不做 Jazz Pharmaceuticals（JAZZ.US）
例行财报日程公告，无业绩数据、指引修正或业务催化，不能形成可交易同向edge。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
🔎 新鲜度:最早出现 2026-07-20 · 扩散 low · price-in 风险 low ↗
关键理由
- 该公告仅是财报披露日期和电话会安排，不包含业绩数据、指引变化、产品进展、监管结果或交易对手信息。
主要风险
- 真正可交易的信息要等2026年8月3日盘后财报和管理层更新披露后再评估。
原文全文
展开原文 · 2,584 字
Skip to main navigation
Top Bar Nav
Contact Us
Social Icons
linkedin
twitter
Home
Jazz Pharmaceuticals to Report Second Quarter Financial Results on August 3, 2026
News Release
News Nav
News
Press Release Archive
Events Archive
Our Stories
Media Contact
Kristin Bhavnani
Head of Global Corporate Communications
Jazz Pharmaceuticals plc
Send Email
Ireland: +353 1 637 2141
US: 215-867-4948
Jazz Pharmaceuticals to Report Second Quarter Financial Results on August 3, 2026
July 20, 2026
PDF Version
DUBLIN , July 20, 2026 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced it will report its 2026 second quarter financial results on Monday, August 3, 2026 , after the close of the U.S . financial markets. Company management will host a webcast at 4:30 p.m. ET to discuss the results and provide a business and financial update.
Interested parties may register for the call in advance here or via the Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com . To ensure a timely connection, it is recommended that participants register at least 15 minutes prior to the scheduled webcast.
A replay of the webcast will be available via the Investors section of the Jazz Pharmaceuticals website at https://investor.jazzpharma.com/investors/events-presentations .
About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharma company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with rare disease — often with limited or no therapeutic options. We have a diverse portfolio of medicines, including leading therapies addressing epilepsies, cancers and sleep disorders. Our patient-focused and science-driven approach powers pioneering research and development advancements across our robust pipeline of innovative therapeutics. Jazz is headquartered in Dublin, Ireland with research and development laboratories, manufacturing facilities and employees in multiple countries committed to serving patients worldwide. Please visit www.jazzpharmaceuticals.com for more information.
Contacts:
Investors:
InvestorInfo@jazzpharma.com
Ireland +353 1 634 3211
U.S. +1 650 496 2717
Media:
CorporateAffairsMediaInfo@jazzpharma.com
Ireland +353 1 637 2141
U.S. +1 215 867 4948
View original content to download multimedia: https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-to-report-second-quarter-financial-results-on-august-3-2026-302829867.html
SOURCE Jazz Pharmaceuticals plc
Top Bar Nav
Contact Us
Social Icons
Home
Jazz Pharmaceuticals to Report Second Quarter Financial Results on August 3, 2026
News Release
News Nav
News
Press Release Archive
Events Archive
Our Stories
Media Contact
Kristin Bhavnani
Head of Global Corporate Communications
Jazz Pharmaceuticals plc
Send Email
Ireland: +353 1 637 2141
US: 215-867-4948
Jazz Pharmaceuticals to Report Second Quarter Financial Results on August 3, 2026
July 20, 2026
PDF Version
DUBLIN , July 20, 2026 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced it will report its 2026 second quarter financial results on Monday, August 3, 2026 , after the close of the U.S . financial markets. Company management will host a webcast at 4:30 p.m. ET to discuss the results and provide a business and financial update.
Interested parties may register for the call in advance here or via the Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com . To ensure a timely connection, it is recommended that participants register at least 15 minutes prior to the scheduled webcast.
A replay of the webcast will be available via the Investors section of the Jazz Pharmaceuticals website at https://investor.jazzpharma.com/investors/events-presentations .
About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharma company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with rare disease — often with limited or no therapeutic options. We have a diverse portfolio of medicines, including leading therapies addressing epilepsies, cancers and sleep disorders. Our patient-focused and science-driven approach powers pioneering research and development advancements across our robust pipeline of innovative therapeutics. Jazz is headquartered in Dublin, Ireland with research and development laboratories, manufacturing facilities and employees in multiple countries committed to serving patients worldwide. Please visit www.jazzpharmaceuticals.com for more information.
Contacts:
Investors:
InvestorInfo@jazzpharma.com
Ireland +353 1 634 3211
U.S. +1 650 496 2717
Media:
CorporateAffairsMediaInfo@jazzpharma.com
Ireland +353 1 637 2141
U.S. +1 215 867 4948
View original content to download multimedia: https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-to-report-second-quarter-financial-results-on-august-3-2026-302829867.html
SOURCE Jazz Pharmaceuticals plc
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。